We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Micro Quartz Optic Device for DNA/RNA Quantification Receives European Patent

By LabMedica International staff writers
Posted on 16 Apr 2012
A European patent has been issue for a novel device that enables precise, straightforward absorbance and fluorescence-based measurements from sample volumes as low as two microliters.

The manufacturer, Tecan (Männedorf, Switzerland), maintains that its NanoQuant Plate's quartz optic array guarantees superior performance and a high rate of reproducibility for up to 16 samples. Designed specifically for use with Tecan's Infinite 200 NanoQuant instrument, this powerful tool is available for DNA/RNA quantification and quality control, providing reliable absorbance readings from as little as two microliters of sample, and can detect DNA concentrations as low as one nanogram per microliter.

 Image: The Infinite 200 NanoQuant instrument (Photo courtesy of Tecan).
Image: The Infinite 200 NanoQuant instrument (Photo courtesy of Tecan).

NanoQuant incorporates flexible i-control software that allows creation of application-oriented measurement scripts using its drag-and-drop interface for effortless set-up of new protocols, which can be saved on the system for future use. Online data presentation provides immediate review and analysis of measurement data, with enhanced data management and straightforward export of data to Microsoft Windows-compatible formats.

Related Links:

Tecan




Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
HPV Test
Allplex HPV28 Detection

Latest BioResearch News

Lung Cancer Study Reveals Cellular Program Behind Therapy Resistance
16 Apr 2012  |   BioResearch

Tumor Genome Marker May Predict Treatment Benefit in Pediatric Cancers
16 Apr 2012  |   BioResearch

Lysosomal Gene Defect Linked to Severe Childhood Brain Disorders
16 Apr 2012  |   BioResearch



ADLM